Publikationen in Zusammenarbeit mit Forschern von Centro Nacional de Investigaciones Cardiovasculares Carlos III (7)

2021

  1. Triglycerides and Residual Atherosclerotic Risk

    Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041

2020

  1. Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design

    American Heart Journal, Vol. 222, pp. 174-182

2014

  1. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)

    Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362

  2. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial"

    Circulation

2013

  1. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    Circulation, Vol. 128, Núm. 14, pp. 1495-1503

2012

  1. Study design for the effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion (METOCARD-CNIC): A randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction

    American Heart Journal, Vol. 164, Núm. 4

2011

  1. Modulation of the beta-adrenergic system during acute myocardial infarction: Rationale for a new clinical trial

    Revista Espanola de Cardiologia, Vol. 64, Núm. SUPPL. 2, pp. 28-33